GenEros Biopharma Hangzhou Ltd
1 clinical trials · Sponsor
◉ Watch GenEros Biopharma Hangzhou Ltd
| Record | Firm | Date |
|---|---|---|
| Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (NCT05768321) | GenEros Biopharma Hangzhou Ltd | 2021-11-04 |
Track GenEros Biopharma Hangzhou Ltd automatically
Every clearance here is in the API, with alerts when new ones post.